Shares of drugmaker Merck & Co. slipped in extremely heavy trading Monday, three days after a Texas jury hit the company with a $253.4 million damage award in the first trial over withdrawn painkiller Vioxx.
While the award likely will be slashed on appeal, the news unsettled investors, cutting the stock's price 3 percent in the first minute of trading. But Merck shares recovered to $27.89 late Monday, down 17 cents.
Comments
LJWorld.com doesn’t necessarily condone the comments here, nor does it review every post. Read our full policy. Also, read about banned accounts and harassing comments.